Evidence map›Paper›PMID 40801231›Full record

ArticleHealth expectations : an international journal of public participation in health care and health policy2025

Barriers and Facilitators to Accessing Healthcare for People With Parkinson's Disease in Latin America: A Qualitative Study.

Christine Jeyachandran, Catherine Spooner, Ana Margarita Rodriguez Salgado, Matthew Prina, Joel Rhee, Jorge Jesus Llibre-Guerra, Dani Kim, Juan J Llibre-Rodriguez, Mark F Harris

Abstract read
In one paragraph

Article in Health expectations : an international journal of public participation in health care and health policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christine JeyachandranThe International Centre for Future Health System, UNSW, Sydney, Australia.ORCID 0000-0002-5625-6895
Catherine SpoonerThe International Centre for Future Health System, UNSW, Sydney, Australia.ORCID 0000-0002-6741-5644
Ana Margarita Rodriguez SalgadoGlobal Brain Health Institute, University of San Francisco, San Francisco, California, USA.ORCID 0000-0001-5993-5466
Matthew PrinaPopulation Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.ORCID 0000-0001-6698-3263
Joel RheeDiscipline of General Practice, School of Clinical Medicine, Faculty of Medicine and Health, UNSW, Sydney, Australia.ORCID 0000-0002-5233-2758
Jorge Jesus Llibre-GuerraDepartment of Neurology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0002-2137-7750
Dani KimHealth Service and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.ORCID 0000-0002-6605-3338
Juan J Llibre-RodriguezDementia Research Unit, Medical University of Havana, Havana, Cuba.
Mark F HarrisThe International Centre for Future Health System, UNSW, Sydney, Australia.ORCID 0000-0002-0705-8913

Funding

This study was supported by the Michael J. Fox Foundation for Parkinson's Research (Grant No. MJFF-020770).
6 · The paper itself

Abstract

aimsThe aim of the study was to identify the barriers and facilitators to healthcare access for people with Parkinson's disease (PWP) in Spanish-speaking Latin American countries (LAC) in Central and South America, to understand their drivers and consider the implications for health systems in LAC.

methodsFour online semi-structured focus groups were conducted with 25 PWP who provide education and/or support to PWP. The study was designed and implemented by a person with lived experience of PD. Data were mapped to an existing model of access to healthcare that incorporates provider and consumer abilities.

findingsThere were multiple provider barriers in terms of availability, affordability and appropriateness of care, driven by a lack of health system capacity. Doctors didn't recognise Parkinson's symptoms, which resulted in delayed diagnosis. Limited knowledge of Parkinson's and limited multidisciplinary care and medication was common across Spanish-speaking Latin America. Inequities in access were experienced by those living in rural areas and those who could not afford private care. Barriers at the person level included stigma, depression and lack of health literacy around PD. Family and peer support were facilitators of access.

conclusionSignificant gaps in Parkinson's care across Latin America are driven by stigma and limited service availability. This study highlights the need for culturally tailored interventions that address stigma, promote peer support and strengthen self-management and health professional training across Spanish-speaking Latin America. We call for more global partnerships to encourage training and mentoring in regional cities across Latin America with co-designed approaches to ensure a culturally appropriate framework of care that supports patients and healthcare professionals with a focus on self-management. PATIENT OR PUBLIC CONTRIBUTION: The first author (C.J.) has Parkinson's disease (PD) and lived with the condition for 8 years in Peru. She was involved in all aspects of the study, including design, data collection, analysis and writing this article. C.J. is an international advocate in the PD community.

Indexed as

Health Services AccessibilityParkinson DiseaseAgedFemaleFocus GroupsHealth LiteracyHumansLatin AmericaMaleMiddle AgedQualitative ResearchSocial Stigmaaccess to healthcarebarrierscarersLatin AmericaParkinson's diseasepeer supportself‐managementstigma

Identifiers

PMID40801231
PMCPMC12344579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.